Table II.
Parameter | Groups | |||
---|---|---|---|---|
CON | DM | Lvil | Hvil | |
Body weight [g] | 554.96 ±20.36 | 479.04 ±10.24** | 508.97 ±14.61**## | 496.26 ±21.49** |
Fasting blood glucose [mmol/l] | 5.14 ±0.36 | 21.04 ±2.15** | 14.27 ±1.36**## | 16.88 ±1.78**## |
AUCgluose [mmol/l/h] | 15.92 ±1.78 | 53.25 ±2.22** | 39.96 ±3.50**## | 42.03 ±5.59**## |
Insulin [mIU/l] | 38.89 ±1.97 | 54.7384 ±6.39** | 37.15 ±6.09## | 36.98 ±7.06## |
HOMA index | 8.87 ±0.62 | 50.95 ±5.61** | 23.37 ±3.35**## | 27.88 ±6.47**## |
TC [mmol/l] | 1.39 ±0.05 | 2.40 ±0.36** | 1.66 ±0.27*## | 1.55 ±0.21## |
TG [mmol/l] | 0.60 ±0.14 | 1.44 ±0.30** | 1.48 ±0.32** | 1.31 ±0.28** |
HDL-C [mmol/l] | 0.59 ±0.08 | 0.42 ±0.08** | 0.59 ±0.10## | 0.50 ±0.08 |
LDL-C [mmol/l] | 0.2 ±0.07 | 0.53 ±0.10** | 0.25 ±0.05## | 0.22 ±0.05## |
CON – control, DM – diabetes mellitus, Lvil – low dose of vildagliptin, Hvil – high dose of vildagliptin.
P < 0.05
p < 0.01 vs. normal control group;
p < 0.01 vs. diabetes group.